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Abstract 
Two human parvoviruses were recently discovered by metagenomics in Africa, bufavirus 
(BuV) in 2012 and tusavirus (TuV) in 2014. These viruses have been studied exclusively 
by PCR in stool and detected only in patients with diarrhoea, although at low 
prevalence. Three genotypes of BuV have been identified. We detected, by in-house 
EIA, BuV1-3 IgG antibodies in 7/228 children (3.1%) and 10/180 adults (5.6%), 
whereas TuV IgG was found in one child (0.4%). All children and 91% of the adults 
were Finnish, yet interestingly 3/6 adults of Indian origin were BuV-IgG positive. By 
competition EIA, no cross-reactivity between the BuVs was detected, indicating that the 
BuV genotypes represent distinct serotypes. Furthermore, we analysed by BuV qPCR 
stool and nasal swab samples from 955 children with gastroenteritis, respiratory illness, 
or both, and found BuV DNA in three stools (0.3%) and for the first time in a nasal 
swab (0.1%). This is the first study documenting the presence of BuV and TuV 
antibodies in humans. Although the seroprevalences of both viruses were low in 
Finland, our results indicate that BuV infections might be widespread in Asia. The BuV-
specific humoral immune responses appeared to be strong and long-lasting, pointing to 
systemic infection in humans. 
